Page last updated: 2024-08-26

artesunic acid and Cytomegalovirus Infections

artesunic acid has been researched along with Cytomegalovirus Infections in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's7 (50.00)24.3611
2020's5 (35.71)2.80

Authors

AuthorsStudies
Bhat, V; Biswas, S; Bonda, A; Chichra, A; Gokarn, A; Jindal, N; Khattry, N; Kumar, S; Mirgh, S; Nayak, L; Prayag, P; Punatar, S; Saroha, M; Shenoy, R; Toshniwal, A; Tripathi, R1
Alain, S; Andouard, D; Chianea, T; El Hamel, C; Hantz, S; Jacquet, C; Marschall, M; Tsogoeva, SB1
Bertzbach, LD; Fröhlich, T; Hahn, F; Herrmann, L; Kaufer, BB; Marschall, M; Müller, R; Tannig, P; Tsogoeva, SB; Wangen, C; Wild, M1
Ackermann, L; Grau, B; Hahn, F; Herrmann, L; Lorion, MM; Marschall, M; Niesar, A; Schütz, M; Tsogoeva, SB; Wild, M1
Arav-Boger, R; Ghosh, AK; Kapoor, A; Lee, H; Mazzone, J; Mukhopadhyay, R; Posner, GH; Roy, S; Zhu, F1
Bertzbach, LD; Frank, T; Fröhlich, T; Hahn, F; Kaufer, BB; Kohrt, S; Marschall, M; Stamminger, T; Tsogoeva, SB1
Bunts, L; Casper, C; Dorsey, G; Gantt, S; Huang, ML; Magaret, A; Rosenthal, PJ; Selke, S; Wald, A1
Alain, S; Brion, JP; Epaulard, O; Germi, R; Lupo, J; Malvezzi, P; Mariette, C; Morand, P; Saint Raymond, C; Thiebaut, A1
Alain, S; Andouard, D; Aubard, Y; Calliste, CA; Cotin, S; Esclaire, F; Hantz, S; Labrousse, F; Morère, L; Ploy, MC; Rawlinson, WD; Saade, F1
Boivin, G; Drouot, E; Piret, J1
John, GT; Lau, PK; Ratanjee, SK; Woods, ML1
Caplan, O; Chou, S; Efferth, T; Marschall, M; Nagler, A; Neumann, AU; Resnick, IB; Rose, J; Shimoni, A; Stamminger, T; Wolf, DG1
Auerochs, S; Bruggeman, CA; Efferth, T; Kalmer, M; Kaptein, SJ; Leis, M; Marschall, M; Rechter, S; Stamminger, T; Vink, C1
Caplan, O; Chou, S; Efferth, T; Lurain, NS; Marschall, M; Neumann, AU; Resnick, IB; Saleh, N; Shapira, MY; Stamminger, T; Wolf, DG1

Trials

1 trial(s) available for artesunic acid and Cytomegalovirus Infections

ArticleYear
An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013, Volume: 58, Issue:1

    Topics: Adolescent; Antimalarials; Antiviral Agents; Artemisinins; Artesunate; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Real-Time Polymerase Chain Reaction; Treatment Outcome; Uganda; Viremia

2013

Other Studies

13 other study(ies) available for artesunic acid and Cytomegalovirus Infections

ArticleYear
Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants.
    Bone marrow transplantation, 2023, Volume: 58, Issue:2

    Topics: Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Virus Activation

2023
A highly potent trimeric derivative of artesunate shows promising treatment profiles in experimental models for congenital HCMV infection in vitro and ex vivo.
    Antiviral research, 2020, Volume: 175

    Topics: Antiviral Agents; Artesunate; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Epithelial Cells; Female; Fibroblasts; Humans; Lung; Organ Culture Techniques; Placenta; Pregnancy; Virus Replication

2020
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice.
    Antiviral research, 2020, Volume: 178

    Topics: Administration, Oral; Animals; Antiviral Agents; Artesunate; Cells, Cultured; Chick Embryo; Cytomegalovirus; Cytomegalovirus Infections; Drugs, Investigational; Humans; Marek Disease; Mice; Virus Replication

2020
The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism.
    International journal of molecular sciences, 2020, Aug-04, Volume: 21, Issue:15

    Topics: Antiviral Agents; Artemisinins; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Fluorescent Dyes; Humans; Mitochondria; Viral Proteins; Virus Replication

2020
Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.
    The Journal of biological chemistry, 2020, 10-30, Volume: 295, Issue:44

    Topics: Antiviral Agents; Artemisinins; Artesunate; Binding Sites; Calpain; Cell Cycle; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Drug Repositioning; Humans; Mass Spectrometry; Phosphorylation; Proteasome Endopeptidase Complex; Vimentin; Virus Replication; Withanolides

2020
Artesunate-derived monomeric, dimeric and trimeric experimental drugs - Their unique mechanistic basis and pronounced antiherpesviral activity.
    Antiviral research, 2018, Volume: 152

    Topics: Antiviral Agents; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Dimerization; Drugs, Investigational; Humans; Microbial Sensitivity Tests; NF-kappa B; Viral Proteins; Virus Replication

2018
Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
    Antiviral research, 2014, Volume: 101

    Topics: Antiviral Agents; Artemisinins; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organ Transplantation; Transplantation; Treatment Outcome; Viral Load

2014
Ex vivo model of congenital cytomegalovirus infection and new combination therapies.
    Placenta, 2015, Volume: 36, Issue:1

    Topics: Adult; Antiviral Agents; Artemisinins; Artesunate; Benzimidazoles; Cytomegalovirus Infections; Female; Flavanones; Humans; Pregnancy; Pregnancy Complications, Infectious; Ribonucleosides; Trophoblasts

2015
Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
    Antiviral therapy, 2016, Volume: 21, Issue:6

    Topics: Antiviral Agents; Artemisinins; Artesunate; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Viral Proteins; Virus Replication

2016
Artesunate is ineffective in controlling valganciclovir-resistant cytomegalovirus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jan-15, Volume: 52, Issue:2

    Topics: Antiviral Agents; Artemisinins; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Treatment Failure; Valganciclovir

2011
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.
    Antiviral research, 2011, Volume: 90, Issue:3

    Topics: Adult; Aged; Antiviral Agents; Artemisinins; Artesunate; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Male; Middle Aged; Viral Load

2011
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
    Antiviral research, 2006, Volume: 69, Issue:2

    Topics: Animals; Antimalarials; Antiviral Agents; Artemisinins; Artesunate; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Ferrous Compounds; Fibroblasts; Herpesviridae Infections; Humans; Immunocompromised Host; Male; Muromegalovirus; Rats; Rats, Inbred Lew; Sesquiterpenes; Specific Pathogen-Free Organisms; Transferrin; Virus Replication

2006
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-01, Volume: 46, Issue:9

    Topics: Antiviral Agents; Artemisinins; Artesunate; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Hematopoietic Stem Cell Transplantation; Humans; Male; Treatment Outcome

2008